Visit link: Burning Rock to Present Validation Data of Magnis BR at the AMP Annual Meeting
Visit link: Burning Rock to Present Validation Data of Magnis BR at the AMP Annual Meeting
Originally posted here: Arcutis Biotherapeutics to Present New Data from ARQ-151 (Topical Roflumilast Cream) Clinical Program at Three Global Dermatology Conferences
Read the rest here: Novartis expands Kymriah® manufacturing footprint with first-ever approved site for commercial CAR-T cell therapy manufacturing in Asia
Read more: Bone Therapeutics Provides Third Quarter 2020 Business Update
The rest is here: Novo Nordisk's operating profit increased by 6% in Danish kroner and by 7% at constant exchange rates (CER) in the first nine months of 2020
See the rest here: Vistin Pharma ASA: Third quarter and YTD 2020 financial results
Read the original here: DBV Technologies Reports September 30, 2020 Cash Position
Go here to see the original: OSE Immunotherapeutics Presents OSE-230 as a Novel Agonist Monoclonal Antibody Therapy Triggering Resolution of Chronic Inflammation
Read this article: Lise Mortensen assumes responsibility as new CFO
Continue reading here: Euro-Australian collaboration offers scalable solutions for biotech: announced at Bio-Europe 2020
Recent Comments